Mozart Therapeutics, Inc. Alternatives & Competitors
12 companies similar to Mozart Therapeutics, Inc. — Orchestrating the Immune System
Companies similar to Mozart Therapeutics, Inc.
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Bastion Therapeutics
Creating a future where inflammatory disorders are curable
London, United Kingdom
Taysha Gene Therapies
Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogeni...
Dallas, United States
Sonoma Biotherapeutics, Inc.
Leading the Next Frontier of Cell Therapy
South San Francisco, Unit...
Rival Readout
Competing with Mozart Therapeutics, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cellenkos, Inc.
Developing off-the-shelf T regulatory (Treg) cell therapies for rare inflammatory diseases...
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Cambridge, United States
Tr1X
Engineering cures for patients with autoimmune & inflammatory diseases.
San Diego, United States
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
Gaithersburg, United Stat...
Gain Therapeutics
Unfolding the next generation of allosteric small molecule therapies to meet patient needs...
Bethesda, United States
Q32 Bio Inc.
Revolutionizing the future of targeted immune therapeutics
Waltham, United States
TRexBio
Decoding Human Tissue Biology to Create Revolutionary Therapeutics
South San Francisco, Unit...
Connect Biopharma
Global Clinical Stage Company Connecting Patients with Innovation for Life
San Diego, United States
About Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc., founded in 2020, is a promising player in the biotechnology industry, based in the United States. With the compelling slogan, "Orchestrating the Immune System," the company is strategically positioned as a clinical-stage biopharmaceutical firm dedicated to developing pioneering therapies for...
Development of CD8 Treg modulators, Research and Development in immunology, Clinical Trials for new therapies, Biologics for autoimmune treatment
Patients with autoimmune diseases, Healthcare providers, Medical researchers, Pharmaceutical investors
Biopharmaceuticals, Clinical-stage, Autoimmune Disease, Disease-modifying Therapies, Immune System Modulation, CD8 Treg Modulators, Immune Homeostasis, Regulatory T Cells, Autoimmune Disorders, Inflammatory Diseases, Immune Surveillance Dysregulation, Immune Balance Restoration
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Mozart Therapeutics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Mozart Therapeutics, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 7 Jun 2025 and 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
